BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2510365)

  • 21. An analysis on transcriptional regulation activity of human XBP1 gene 5' upstream DNA sequences.
    Guo FJ; Cheng HE; Yi FP; Peng HM; Song FZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):1-6. PubMed ID: 16456775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
    Anisowicz A; Sotiropoulou G; Sager R
    Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements.
    Hunninghake GW; Monick MM; Liu B; Stinski MF
    J Virol; 1989 Jul; 63(7):3026-33. PubMed ID: 2542610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of promoter and enhancer cell type specificities and the regulation of immunoglobulin gene expression.
    Doyen N; Leblond-Francillard M; Holm I; Dreyfus M; Rougeon F
    Gene; 1986; 50(1-3):321-31. PubMed ID: 3495468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a transcription factor that binds to the S box of the I-A beta gene of the major histocompatibility complex.
    Celada A; Gil P; McKercher SR; Maki RA
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):737-44. PubMed ID: 8611149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells.
    Penix L; Weaver WM; Pang Y; Young HA; Wilson CB
    J Exp Med; 1993 Nov; 178(5):1483-96. PubMed ID: 8228802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, and DOB genes.
    Voliva CF; Tsang S; Peterlin BM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3408-12. PubMed ID: 8475089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression.
    Williams TM; Eisenberg L; Burlein JE; Norris CA; Pancer S; Yao D; Burger S; Kamoun M; Kant JA
    J Immunol; 1988 Jul; 141(2):662-6. PubMed ID: 2838551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
    Sun Z; Kitchingman GR
    Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
    Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
    Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma response region in the promoter of the class II MHC gene, DPA.
    Sugawara M; Ponath PD; Yang Z; Strominger JL
    Hum Immunol; 1992 Nov; 35(3):157-64. PubMed ID: 1363420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression.
    Sugawara M; Ponath PD; Shin J; Yang Z; Strominger JL
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10347-51. PubMed ID: 1946454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of luteinising hormone-beta subunit chloramphenicol acetyltransferase (LH-beta-CAT) fusion gene in rat pituitary cells: induction by cyclic 3'-adenosine monophosphate (cAMP).
    Clayton RN; Lalloz MR; Salton SR; Roberts JL
    Mol Cell Endocrinol; 1991 Sep; 80(1-3):193-202. PubMed ID: 1659545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of the human H1 zero-histone-gene transcription in human tumor-cell lines.
    Bouterfa HL; Triebe SM; Doenecke DR
    Eur J Biochem; 1993 Oct; 217(1):353-60. PubMed ID: 8223573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional activity of the hamster CYP11B2 promoter in NCI-H295 cells stimulated by angiotensin II, potassium, forskolin and bisindolylmaleimide.
    LeHoux JG; Lefebvre A
    J Mol Endocrinol; 1998 Apr; 20(2):183-91. PubMed ID: 9584833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines.
    Sloan JH; Boss JM
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8186-90. PubMed ID: 2903501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene.
    Sherman PA; Basta PV; Ting JP
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4254-8. PubMed ID: 3495805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
    Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
    Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.
    Kwok WW; Mickelson E; Masewicz S; Milner EC; Hansen J; Nepom GT
    J Exp Med; 1990 Jan; 171(1):85-95. PubMed ID: 2104922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.